A Comprehensive Review of the Role of Hemogram Derived Inflammatory Markers in Gastrointestinal Conditions

Document Type : Review Article

Authors

Abant Izzet Baysal University Hospital, Department of Internal Medicine, Bolu, Turkey

Abstract

Inflammation, even overt or subtle, has an important role in the pathogenesis of various diseases. Hemogram derived markers are novel inflammatory predictors and have been studied by the authors in different settings, including gastrointestinal conditions. Of those, mostly used indices are mean platelet volume (MPV), red cell distribution width (RDW), neutrophil-to-lymphocyte ratio(NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio. Besides the well-established roles of these markers in various hematological issues, including differentiating anemia, platelet activation and infections, recent literature suggest that they could be associated with the inflammatory burden in gastrointestinal conditions from inflammatory disease to functional disorders and malignancies. In present work, we aimed to review the literature to reveal the association between these markers and gastrointestinal diseases to establish their diagnostic and prognostic role in disorders of the gastrointestinal system. In present work, we aimed to review the literature to reveal the association between these markers and gastrointestinal diseases to establish their diagnostic and prognostic role in disorders of the gastrointestinal system.

Keywords

References

  1.  

    1. Aktas G, Sit M, Tekce H, Alcelik A, Savli H, Simsek T, et al. Mean platelet volume in nasal polyps. The West Indian medical journal. 2013;62(6):515-8.
    2. Cakır L, Aktas G, Mercimek OB, Enginyurt O, Kaya Y, Mercimek K. Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis. Biomed Res. 2016;27(2):292-4.
    3. Aktas G, Kocak MZ, Duman TT, Erkus E, Atak BM, Sit M, et al. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Medical Journal. 2018;7(3):650-3.
    4. Cakir L, Aktas G, Enginyurt O, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterranea. 2014;30(2):425-8.
    5. Aktaş G, Çakıroğlu B, Şit M, Üyetürk U, Alçelik A, Savlı H, et al. Mean platelet volume: a simple indicator of chronic prostatitis. Acta Medica Mediterranea. 2013;29:551-4.
    6. Dagistan Y, Dagistan E, Gezici AR, Halicioglu S, Akar S, Özkan N, et al. Could red cell distribution width and mean platelet volume be a predictor for lumbar disc hernias? Ideggyogyaszati szemle. 2016;69(11-12):411-4.
    7. Aktas G, Sit M, Dikbas O, Tekce BK, Savli H, Tekce H, et al. Could red cell distribution width be a marker in Hashimoto's thyroiditis? Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2014;122(10):572-4.
    8. Ustaoglu M, Aktas G, Avcioglu U, Bas B, Bahceci BK. Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases. European journal of gastroenterology & hepatology. 2021;33(1S Suppl 1):e905-e8.
    9. Bilgin S, Tel BMA, Kahveci G, Duman TT, Kurtkulagi O, Yurum S, et al. Hypothyroidism is Strongly Correlated with Mean Platelet Volume and Red Cell Distribution Width. National Journal of Health Sciences. 2021;6(1):7-10.
    10. Tekce H, Kin Tekce B, Aktas G, Tanrisev M, Sit M. The evaluation of red cell distribution width in chronic hemodialysis patients. International journal of nephrology. 2014;2014:754370.
    11. Şahin Ş, Sarıkaya S, Alcelik A, Erdem A, Taşlıyurt T, Akyol L, et al. Neutrophil to lymphocyte ratio is a useful predictor of atrial fibrillation in patients with diabetes mellitus. Acta medica mediterranea. 2013;29:847-51.
    12. Aktas G, Sit M, Dikbas O, Erkol H, Altinordu R, Erkus E, et al. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis. Revista da Associacao Medica Brasileira (1992). 2017;63(12):1065-8.
    13. Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. African health sciences. 2019;19(1):1602-6.
    14. Afsin H, Aktas G. Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios are useful in differentiation of thyroid conditions with normal and increased uptake. Ethiopian Journal of Health Development. 2021;35(3):1-5.
    15. Aktas G. Hematological predictors of novel Coronavirus infection. Revista da Associacao Medica Brasileira (1992). 2021;67Suppl 1(Suppl 1):1-2.
    16. Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Revista da Associacao Medica Brasileira (1992). 2019;65(1):38-42.
    17. Atak BM, Kahveci GB, Bilgin S, Kurtkulagi O, Kosekli MA. Platelet to lymphocyte ratio in differentiation of benign and malignant thyroid nodules. Experimental Biomedical Research. 2021;4(2):148-53.
    18. Kocak MZ, Aktas G, Duman TT, Atak BM, Kurtkulagi O, Tekce H, et al. Monocyte lymphocyte ratio As a predictor of Diabetic Kidney Injury in type 2 Diabetes mellitus; The MADKID Study. Journal of diabetes and metabolic disorders. 2020;19(2):997-1002.
    19. Tel BMA, Bilgin S, Kurtkulagi O, Kahveci G, Duman TT, Sagdic T, et al. Frailty in Diabetic Subjects during COVID-19 and Its Association with HbA1c, Mean Platelet Volume and Monocyte/Lymphocyte Ratio. Clinical Diabetology. 2022;11(2):119-26.
    20. Catal O, Ozer B, Sit M, Aktas G, Erkol H. The role of monocyte to lymphocyt ratio in predicting metastasis in rectal cancer. Annals of Medical Research. 2021;28(3):527-31.
    21. Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. Journal of clinical laboratory analysis. 2011;25(3):162-5.
    22. Beyazit Y, Sayilir A, Torun S, Suvak B, Yesil Y, Purnak T, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clinics and research in hepatology and gastroenterology. 2012;36(2):162-8.
    23. Osada J, Wereszczynska-Siemiatkowska U, Dabrowski A, Dabrowska MI. Platelet activation in acute pancreatitis. Pancreas. 2012;41(8):1319-24.
    24. Okuturlar Y, Soylu A, Dogan H, Cakmak S, Kirac Utku I, Oztosun B, et al. Mean platelet volume in patients with biliary and non-biliary acute pancreatitis. International journal of clinical and experimental pathology. 2015;8(2):2051-6.
    25. Lei JJ, Zhou L, Liu Q, Xiong C, Xu CF. Can mean platelet volume play a role in evaluating the severity of acute pancreatitis? World journal of gastroenterology. 2017;23(13):2404-13.
    26. Kefeli A, Basyigit S, Özgür Yeniova A, Küçükazman M, Nazligül Y, Aktas B. Platelet Number and Indexes during Acute Pancreatitis. Euroasian journal of hepato-gastroenterology. 2014;4(2):67-9.
    27. Yarkaç A, Kose A, Bozkurt Babuş S, Ates F, Orekici Temel G, Ölmez A. The value of hematological parameters in acute pancreatitis. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES. 2019;25(5):453-60.
    28. Lee WS, Kim TY. Alcoholic fatty liver disease and alcoholic liver cirrhosis may be differentiated with mean platelet volume and platelet distribution width. Platelets. 2010;21(7):584-5.
    29. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Medical science monitor : international medical journal of experimental and clinical research. 2010;16(4):Cr202-5.
    30. Ozhan H, Aydin M, Yazici M, Yazgan O, Basar C, Gungor A, et al. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets. 2010;21(1):29-32.
    31. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Current pharmaceutical design. 2011;17(1):47-58.
    32. Qi XT, Wan F, Lou Y, Ye B, Wu D. The mean platelet volume is a potential biomarker for cirrhosis in chronic hepatitis B virus infected patients. Hepato-gastroenterology. 2014;61(130):456-9.
    33. Hu Y, Lou Y, Chen Y, Mao W. Evaluation of mean platelet volume in patients with hepatitis B virus infection. International journal of clinical and experimental medicine. 2014;7(11):4207-13.
    34. Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clinics and research in hepatology and gastroenterology. 2013;37(1):41-6.
    35. Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozguneş N, et al. A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection. Wiener klinische Wochenschrift. 2013;125(15-16):453-60.
    36. Arhan M, Onal İK, Tas A, Kurt M, Kalkan IH, Ozin Y, et al. The role of red cell distribution width as a marker in inflammatory bowel disease. Turkish Journal of Medical Sciences. 2011;41(2):227-34.
    37. Yeşil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdaş Övünç AO. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut and liver. 2011;5(4):460-7.
    38. Aktas G, Alcelik A, Tekce BK, Tekelioglu V, Sit M, Savli H. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Przeglad gastroenterologiczny. 2014;9(3):160-3.
    39. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet (London, England). 2003;361(9356):512-9.
    40. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology. 2003;124(6):1662-71.
    41. Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123(6):1972-9.
    42. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. American journal of physiology Gastrointestinal and liver physiology. 2012;303(7):G775-85.
    43. Tahtaci M, Yurekli OT, Bolat AD, Balci S, Akin FE, Buyukasik NS, et al. Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis. European journal of gastroenterology & hepatology. 2015;27(12):1382-5.
    44. Tang J, Gao X, Zhi M, Zhou HM, Zhang M, Chen HW, et al. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP. Journal of digestive diseases. 2015;16(3):118-24.
    45. Montgomery SM, Ekbom A. Epidemiology of inflammatory bowel disease. Current opinion in gastroenterology. 2002;18(4):416-20.
    46. Douda T, Bures J, Rejchrt S, Kopácová M, Pecka M, Malý J. [Mean platelet volume (MPV) in Crohn's disease patients]. Casopis lekaru ceskych. 2006;145(11):870-3.
    47. Zubcevic N, Mesihovic R, Zubcevic S. Usefulness of laboratory data in estimation of Crohn's disease activity. Medicinski arhiv. 2010;64(1):33-6.
    48. Yüksel O, Helvaci K, Başar O, Köklü S, Caner S, Helvaci N, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009;20(4):277-81.
    49. Polińska B, Matowicka-Karna J, Kemona H. [The cytokines in inflammatory bowel disease]. Postepy higieny i medycyny doswiadczalnej (Online). 2009;63:389-94.
    50. Järemo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thrombosis and haemostasis. 1996;75(4):560-1.
    51. Saler T, Keşkek ŞÖ, Ergin C, Ahbab S, Sağlam Z. Mean platelet volume in patients with inflammatory bowel. Gen Int Med Clin Innov. 2016;1(3):40-3.
    52. Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World journal of gastroenterology. 2008;14(16):2474-86.
    53. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420(6913):333-6.
    54. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (New York, NY). 2004;306(5695):457-61.
    55. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li Z-W, Karin M, et al. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science (New York, NY). 2001;293(5535):1673-7.
    56. Aktas G, Alcelik A, Tekce BK, Savlı H, Uyeturk U, Kurt M, et al. Mean platelet volume and red cell distribution width in hepatosteatosis. National journal of medical research. 2013;3(03):264-6.
    57. Shin WY, Jung DH, Shim JY, Lee HR. The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. Platelets. 2011;22(6):442-6.
    58. Madan SA, John F, Pitchumoni CS. Nonalcoholic Fatty Liver Disease and Mean Platelet Volume. Journal of clinical gastroenterology. 2016;50(1):69-74.
    59. Yin JB, Wang X, Zhang X, Liu L, Wang RT. Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases. Scientific reports. 2018;8(1):6014.
    60. Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy. Asian Pacific journal of cancer prevention : APJCP. 2014;15(15):6421-3.
    61. Kurt M, Onal IK, Sayilir AY, Beyazit Y, Oztas E, Kekilli M, et al. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepato-gastroenterology. 2012;59(117):1580-2.
    62. Kılınçalp S, Ekiz F, Başar O, Ayte MR, Coban S, Yılmaz B, et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets. 2014;25(8):592-4.
    63. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. International journal of cardiology. 2013;167(4):1412-6.
    64. Wang D, Yang J, Zhang J, Zhang S, Wang B, Wang R, et al. Red cell distribution width predicts deaths in patients with acute pancreatitis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2015;20(5):424-8.
    65. Goyal H, Awad H, Hu ZD. Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. Annals of translational medicine. 2017;5(17):342.
    66. Li Y, Zhao Y, Feng L, Guo R. Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study. BMJ open. 2017;7(3):e013206.
    67. Hu Z-D, Chen Y, Zhang L, Sun Y, Huang Y-L, Wang Q-Q, et al. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Clinica chimica acta. 2013;425:202-5.
    68. Yao J, Lv G. Association between red cell distribution width and acute pancreatitis: a cross-sectional study. BMJ open. 2014;4(8):e004721.
    69. Gravito-Soares M, Gravito-Soares E, Gomes D, Almeida N, Tomé L. Red cell distribution width and red cell distribution width to total serum calcium ratio as major predictors of severity and mortality in acute pancreatitis. BMC gastroenterology. 2018;18(1):108.
    70. Singh VB, Kumar H, Kumar R, Meena BL, Chandra S. Correlation of red cell distribution width with the severity of acute pancreatitis. Journal of Current Research in Scientific Medicine. 2020;6(2):123.
    71. Zhang FX, Li ZL, Zhang ZD, Ma XC. Prognostic value of red blood cell distribution width for severe acute pancreatitis. World journal of gastroenterology. 2019;25(32):4739-48.
    72. Fan X, Deng H, Wang X, Fu S, Liu Z, Sang J, et al. Association of red blood cell distribution width with severity of hepatitis B virus-related liver diseases. Clinica chimica acta; international journal of clinical chemistry. 2018;482:155-60.
    73. Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PloS one. 2013;8(7):e68780.
    74. Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PloS one. 2012;7(5):e37644.
    75. Sembiring J, Jones F, editors. Diagnostic accuracy of liver fibrosis based on red cell distribution width (RDW) to platelet ratio with fibroscan in chronic hepatitis B. IOP Conference Series: Earth and Environmental Science; 2018: IOP Publishing.
    76. Zhu M, Han M, Xiao X, Lu S, Guan Z, Song Y, et al. Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study. International journal of medical sciences. 2019;16(5):720-8.
    77. Idris F, Muhadi D, Mutmainah M. Analysis of red blood cell distribution width value towards fibrotic stage in chronic Hepatitis B. Indonesian Journal of Clinical Pathology and Medical Laboratory 2018;25(1):95-8.
    78. Canani RB, De Horatio LT, Terrin G, Romano MT, Miele E, Staiano A, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition. 2006;42(1):9-15.
    79. Cakal B, Akoz AG, Ustundag Y, Yalinkilic M, Ulker A, Ankarali H. Red cell distribution width for assessment of activity of inflammatory bowel disease. Digestive diseases and sciences. 2009;54(4):842-7.
    80. Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ, et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Digestive diseases and sciences. 2012;57(4):1033-8.
    81. Atak BM, Erkus E, Duman TT, Kocak MZ, Kosekli MA. Mean Platelet volume to platelet and red cell distribution width to platelet ratios in Irritable Bowel Syndrome. Experimental Biomedical Research. 2018;1(2):60-3.
    82. Kahveci G, Aktas G, Tel BA, Bilgin S, Kurtkulagi O, Balci B, et al. Red cell distribution width-to-platelet count ratio is a promising predictor of functional bowel disease. Family Medicine & Primary Care Review.24(2):126-9.
    83. Brunt EM, editor Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Seminars in diagnostic pathology; 2005: Elsevier.
    84. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Seminars in liver disease. 2008;28(4):339-50.
    85. Liu F, Zhou H, Cao L, Guo Z, Dong C, Yu L, et al. Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study. Lipids in health and disease. 2018;17(1):221.
    86. Cengiz M, Candır BA, Yılmaz G, Akyol G, Ozenirler S. Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? World journal of gastroenterology. 2013;19(42):7412-8.
    87. Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, et al. Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. Clinical and molecular hepatology. 2013;19(3):258-65.
    88. Yang W, Huang H, Wang Y, Yu X, Yang Z. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease. European journal of gastroenterology & hepatology. 2014;26(2):174-8.
    89. Montagnana M, Danese E. Red cell distribution width and cancer. Annals of translational medicine. 2016;4(20):399.
    90. Saito H, Shimizu S, Shishido Y, Miyatani K, Matsunaga T, Fujiwara Y. Prognostic significance of the combination of preoperative red cell distribution width and platelet distribution width in patients with gastric cancer. BMC cancer. 2021;21(1):1317.
    91. Smirne C, Grossi G, Pinato DJ, Burlone ME, Mauri FA, Januszewski A, et al. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2015;47(6):488-94.
    92. Fang Y, Sun X, Zhang L, Xu Y, Zhu W. Hemoglobin/Red Blood Cell Distribution Width Ratio in Peripheral Blood Is Positively Associated with Prognosis of Patients with Primary Hepatocellular Carcinoma. Medical science monitor : international medical journal of experimental and clinical research. 2022;28:e937146.
    93. Wen ZL, Zhou X, Xiao DC. Is red blood cell distribution width a prognostic factor for colorectal cancer? A meta-analysis. Frontiers in surgery. 2022;9:945126.
    94. Fancellu A, Zinellu A, Mangoni AA, Popova A, Galotti F, Feo CF, et al. Red Blood Cell Distribution Width (RDW) Correlates to the Anatomical Location of Colorectal Cancer. Implications for Clinical Use. Journal of gastrointestinal cancer. 2022;53(2):259-64.
    95. Kattepur AK, Patkar S, Ramaswamy A, Ostwal V, Goel M. Red Cell Distribution Width and Gallbladder Cancer: Is It Really Useful? Journal of gastrointestinal cancer. 2022;53(4):995-1005.
    96. Posul E, Yilmaz B, Aktas G, Kurt M. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wiener klinische Wochenschrift. 2015;127(7-8):262-5.
    97. Langley BO, Guedry SE, Goldenberg JZ, Hanes DA, Beardsley JA, Ryan JJ. Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review. Journal of clinical medicine. 2021;10(18).
    98. Dai C, Jiang M, Huang YH. Neutrophil-to-Lymphocyte Ratio for the Diagnosis and Monitoring of Inflammatory Bowel Disease. Digestive diseases and sciences. 2022.
    99. Metwally RH. Can Neutrophil/Lymphocyte Ratio Assess Inflammatory Bowel Disease Activity and Severity in Children? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2022.
    100. Fu W, Fu H, Ye W, Han Y, Liu X, Zhu S, et al. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: A meta-analysis. International immunopharmacology. 2021;101(Pt B):108235.
    101. Tsunoda J, Shigeta K, Matsui S, Seishima R, Okabayashi K, Kitagawa Y. Neutrophil-to-Lymphocyte Ratio is a Useful Biomarker for Predicting Postoperative Complications in Crohn's Disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2022;26(7):1516-9.
    102. Aktaş G, Duman TT, Atak B, Kurtkulağı Ö, Bilgin S, Başaran E, et al. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Family Medicine and Primary Care Review. 2020;22(2):107–10.
    103. Güçlü M, Ağan AF. Relationship of peripheral blood neutrophil to lymphocyte ratio and irritable bowel syndrome. Turk J Med Sci. 2017;47(4):1067-71.
    104. Aktas G, Duman TT, Kurtkulagi O, Tel BMA, Bilgin S, Kahveci G, et al. Liver steatosis is associated both with platelet distribution width, neutrophil/lymphocyte and monocyte/lymphocyte ratios. Primary Health Care: Open Access. 2020;10(4):1-4.
    105. WenYi J, Ting Q, PiaoPiao Y, JinMing W. Association Between Neutrophil-to-Lymphocyte Ratio with Inflammatory Activity and Fibrosis in Non-alcoholic Fatty Liver Disease. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2022;33(1):53-61.
    106. Lesmana CRA, Kencana Y, Rinaldi I, Kurniawan J, Hasan I, Sanityoso Sulaiman A, et al. Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP). Diabetes, metabolic syndrome and obesity : targets and therapy. 2022;15:15-22.
    107. Thomas CE, Yu YC, Luu HN, Wang R, Paragomi P, Behari J, et al. Neutrophil-lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Cancer medicine. 2022.
    108. Zhou Y, Tian N, Li P, He Y, Tong L, Xie W. The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study. European journal of gastroenterology & hepatology. 2022;34(11):1158-64.
    109. Lee SH, Lee TY, Cheon YK. The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Medicina (Kaunas, Lithuania). 2021;58(1).
    110. Lu Z, Chen X, Ge H, Li M, Feng B, Wang D, et al. Neutrophil-Lymphocyte Ratio in Patients with Hypertriglyceridemic Pancreatitis Predicts Persistent Organ Failure. Gastroenterology research and practice. 2022;2022:8333794.
    111. Karabuga B, Gemcioglu E, Konca Karabuga E, Baser S, Ersoy O. Comparison of the predictive values of CRP, CRP/albumin, RDW, neutrophil/lymphocyte, and platelet/lymphocyte levels in determining the severity of acute pancreatitis in patients with acute pancreatitis according to the BISAP score. Bratislavske lekarske listy. 2022;123(2):129-35.
    112. Gupta P, Das GC, Bansal A, Samanta J, Mandavdhare HS, Sharma V, et al. Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitis. World journal of clinical cases. 2022;10(1):91-103.
    113. Gou M, Qu T, Wang Z, Yan H, Si Y, Zhang Y, et al. Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer. Journal of immunology research. 2021;2021:2549295.
    114. Liu Z, Liang Y, Tang X, Qu H. Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer. Frontiers in surgery. 2021;8:745748.
    115. Booka E, Kikuchi H, Haneda R, Soneda W, Kawata S, Murakami T, et al. Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer. Anticancer research. 2022;42(6):2977-87.
    116. Lin N, Li J, Yao X, Zhang X, Liu G, Zhang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: A meta-analysis of results from multivariate analysis. International journal of surgery (London, England). 2022;107:106959.
    117. Ming-Sheng F, Mei-Ling D, Xun-Quan C, Yuan-Xin H, Wei-Jie Z, Qin-Cong P. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer. Canadian journal of gastroenterology & hepatology. 2022;2022:3109165.
    118. Reddy CS, Karimaddela K, Theja P, Prakash GV, Kumar PM. Role of platelet to lymphocyte ratio in assessing prognosis in acute pancreatitis. International Surgery Journal. 2019;6(3):853-6.
    119. Cho SK, Jung S, Lee KJ, Kim JW. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio can predict the severity of gallstone pancreatitis. BMC gastroenterology. 2018;18(1):18.
    120. Liu G, Tao J, Zhu Z, Wang W. The early prognostic value of inflammatory markers in patients with acute pancreatitis. Clinics and research in hepatology and gastroenterology. 2019;43(3):330-7.
    121. Lu W, Zhang Y, Zhu H, Zhang T, Zhang L, Gao N, et al. Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection. British Journal of Biomedical Science. 2019;76(3):137-42.
    122. Zhao Z, Liu J, Wang J, Xie T, Zhang Q, Feng S, et al. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection. International immunopharmacology. 2017;51:1-8.
    123. Li X, Wang L, Gao P. Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis. Medicine. 2019;98(39):e17300.
    124. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology (Baltimore, Md). 2015;61(1):292-302.
    125. Avanzas P, Quiles J, López de Sá E, Sánchez A, Rubio R, García E, et al. Neutrophil count and infarct size in patients with acute myocardial infarction. International journal of cardiology. 2004;97(1):155-6.
    126. Meng X, Wei G, Chang Q, Peng R, Shi G, Zheng P, et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2016;45:72-7.
    127. Jeong Y, Jeon SR, Kim HG, Moon JR, Lee TH, Jang JY, et al. The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis. Intestinal research. 2021;19(1):62-70.
    128. Akpinar MY, Ozin YO, Kaplan M, Ates I, Kalkan IH, Kilic ZMY, et al. Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis. Journal of medical biochemistry. 2018;37(2):155-62.
    129. Fidan K, Kocak MZ. Assessment of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ulcerative colitis: a retrospective study. Eurasian J Med Oncol. 2017;1:224-7.
    130. Feng JR, Qiu X, Wang F, Chen PF, Gao Q, Peng YN, et al. Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn's Disease. Gastroenterology research and practice. 2017;2017:3526460.
    131. Lee HB, Kim JH, Yim CY, Kim DG, Ahn DS. Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease. The Korean journal of internal medicine. 1997;12(1):7-15.
    132. Segal AW. How neutrophils kill microbes. Annual review of immunology. 2005;23:197.
    133. Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, et al. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis. The Kaohsiung journal of medical sciences. 2015;31(11):585-90.
    134. Gao SQ, Huang LD, Dai RJ, Chen DD, Hu WJ, Shan YF. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity. International journal of clinical and experimental pathology. 2015;8(11):14779-85.
    135. Bedel C. Can we use neutrophil lymphocyte ratio and platelet lymphocyte ratio as a potential biomarker for acute cholecystitis? Ortadoğu Tıp Dergisi. 2019;11(4):404-8.
    136. Black CJ, Ford AC. Irritable bowel syndrome: a spotlight on future research needs. The lancet Gastroenterology & hepatology. 2021;6(6):419-22.
    137. Purón-González E, González-Cantú A, Coronado-Alejandro EU, Sánchez-Dávila OE, Cobos-Aguilar H, Romero-Ibarguengoitia ME. Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. European journal of gastroenterology & hepatology. 2021;33(10):1316-21.
    138. Michalak A, Cichoż-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, et al. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. World journal of gastroenterology. 2020;26(47):7538-49.
    139. Li W, Tao L, Lu M, Xiu D. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients. Medicine. 2018;97(8):e9616.
    140. Goubran HA, Stakiw J, Radosevic M, Burnouf T. Platelets effects on tumor growth. Seminars in oncology. 2014;41(3):359-69.
    141. Amo L, Tamayo-Orbegozo E, Maruri N, Eguizabal C, Zenarruzabeitia O, Riñón M, et al. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Frontiers in oncology. 2014;4:245.
    142. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-48.
    143. Sierko E, Wojtukiewicz MZ, editors. Platelets and angiogenesis in malignancy. Seminars in thrombosis and hemostasis; 2004: Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New ….
    144. Hutterer GC, Krieger D, Mrsic E, Pohlmann K, Bezan A, Stojakovic T, et al. Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma. Anticancer research. 2015;35(6):3463-9.
    145. Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. International journal of cancer. 2012;130(12):2747-60.
    146. Zhang X, Zhao W, Yu Y, Qi X, Song L, Zhang C, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World journal of surgical oncology. 2020;18(1):191.
    147. Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. Journal of surgical oncology. 2014;110(3):333-40.
    148. Nissen M, Tröbs RB. The lymphocyte-to-monocyte ratio may distinguish complicated from non-complicated pediatric appendicitis: A retrospective study and literature review. Pediatrics and neonatology. 2022;63(2):146-53.
    149. Duyan M, Vural N. Diagnostic value of monocyte-lymphocyte ratio and red cell distribution width- lymphocyte ratio against other biomarkers in children with acute appendicitis, cross-sectional study. Tropical doctor. 2022;52(4):510-4.
    150. Salehi A, Dehghani SM, Vardenjani HM, Darban B, Ghandour F. Comparison of lymphocyte-to-monocyte ratio with Child-Pugh and PELD/MELD scores to predict the outcome of children with cirrhosis. Clinical and experimental hepatology. 2021;7(4):351-7.
    151. Ishida N, Asai Y, Miyazu T, Tamura S, Tani S, Yamade M, et al. Lymphocyte-to-monocyte ratio is a short-term predictive marker of ulcerative colitis after induction of advanced therapy. Gastroenterology report. 2022;10:goac025.
    152. Cherfane CE, Gessel L, Cirillo D, Zimmerman MB, Polyak S. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflammatory bowel diseases. 2015;21(8):1769-75.
    153. Okba AM, Amin MM, Abdelmoaty AS, Ebada HE, Kamel AH, Allam AS, et al. Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Auto- immunity highlights. 2019;10(1):4.
    154. Zhu Y, Zhao W, Mao G. Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer. Journal of gastrointestinal oncology. 2022;13(3):1007-21.
    155. Hamid HKS, Emile SH, Davis GN. Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review, Meta-analysis, and Meta-regression. Diseases of the colon and rectum. 2022;65(2):178-87.
    156. Wang Q, Qiao W, Liu B, Li J, Yuan C, Long J, et al. The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy. BMC gastroenterology. 2022;22(1):98.
    157. Zhu ZF, Zhuang LP, Zhang CY, Ning ZY, Wang D, Sheng J, et al. Predictive role of the monocyte-to-lymphocyte ratio in advanced hepatocellular carcinoma patients receiving anti-PD-1 therapy. Translational cancer research. 2022;11(1):160-70.
    158. Kubota K, Shimizu A, Notake T, Masuo H, Hosoda K, Yasukawa K, et al. Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma. Annals of surgical oncology. 2022;29(2):1437-48.
    159. Gawiński C, Michalski W, Mróz A, Wyrwicz L. Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients. Biology. 2022;11(3).
    160. Gupta V, Chaudhari V, Shrikhande SV, Bhandare MS. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study. Journal of gastrointestinal cancer. 2022;53(3):641-8.
Iranian Journal of Colorectal Research
Volume 10, Issue 3
September 2022
Pages 75-86

Files

Share

How to cite

Statistics